Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis

Fatemeh Siavoshi, Rezvan Noroozi, Gina Chang, Vinícius Andreoli Schoeps, Matthew D. Smith, Farren Briggs, Jennifer Graves, Emmanuelle Waubant, Ellen M. Mowry, Peter A. Calabresi, Pavan Bhargava, Kathryn C. FitzgeraldmedRxiv 2025 · DOI

This research paper explores the intersection of biological aging, chronic disease, and social environment. By utilizing "metabolomic clocks," the authors demonstrate that Multiple Sclerosis (MS) significantly accelerates biological aging from its earliest stages and that social disadvantage further compounds this effect.

TL;DR

People with Multiple Sclerosis (MS) exhibit significantly faster biological aging—measured via blood metabolites—than healthy individuals, a process that begins as early as childhood. Crucially, this "age acceleration" is linked to social disadvantage, suggesting that socioeconomic factors directly exacerbate the biological toll of the disease.

What Problem Does This Paper Address?

Multiple Sclerosis is a notoriously heterogeneous disease; two patients of the same chronological age can have vastly different levels of disability and progression. Chronological age (years since birth) is a "blunt instrument" that fails to capture the underlying cellular and physiological health of a patient.

Biological age, however, offers a more precise reflection of health status. While previous studies have looked at biological aging through DNA methylation or telomere length, this paper focuses on metabolomic age (mAge). Metabolites are the downstream products of complex biological processes influenced by genetics, diet, and environment. The authors sought to determine if MS causes the biological clock to run faster and whether Social Determinants of Health (SDoH)—the non-medical factors like where people live and work—influence this acceleration.

Methods

The researchers employed a "metabolomic aging clock" previously trained on a massive dataset of ~12,000 healthy adults. This clock uses Ridge regression to predict age based on the levels of hundreds of metabolites in the blood.

The study calculated Age Acceleration, defined as the difference between a person's predicted metabolomic age and their actual chronological age. They analyzed three distinct cohorts to ensure the findings weren't just a result of long-term medication or advanced disease:

  1. JHU Cohort: A broad group of adult patients at various disease stages.
  2. UMMSM Cohort: Adult patients who were "DMT-naïve" (had not yet started disease-modifying therapies).
  3. UCSF Cohort: Pediatric-onset MS patients (onset before age 18).

To measure social disadvantage, they used the Area Deprivation Index (ADI), a composite score based on census data (income, education, housing quality, etc.) linked to the participants' home addresses.

Datasets

The study pooled data from three major clinical research sites:

  • Johns Hopkins University (JHU): 323 people with MS (PwMS) and 66 healthy controls (HCs).
  • University of Miami (UMMSM): 71 DMT-naïve PwMS and 101 HCs.
  • University of California, San Francisco (UCSF): 67 pediatric-onset MS patients and 64 HCs.

Key Insights and Ideas

  • Aging Starts Early: Perhaps the most striking finding is that age acceleration was present in the pediatric cohort. This suggests that the biological "weathering" associated with MS begins almost immediately upon disease onset, rather than being a late-stage consequence of decades of inflammation.
  • Independent of Medication: Because acceleration was observed in DMT-naïve patients, the researchers could conclude that the faster aging is likely driven by the disease pathology itself (chronic inflammation, oxidative stress), rather than being a side effect of MS treatments.
  • The "Social Multiplier": The study provides biological evidence for how social inequality "gets under the skin." Higher levels of neighborhood deprivation (ADI) were significantly correlated with even faster biological aging, suggesting that social stress acts as a catalyst for disease-related biological decline.
  • Metabolomics as a Holistic Mirror: Unlike telomere length, which measures a specific cellular marker, the metabolome reflects a broad spectrum of physiological changes, including mitochondrial dysfunction and environmental exposures, making it a robust "multidimensional portrait" of aging.

Key Results

  • Cross-sectional Acceleration: Adult PwMS were biologically 9.77 years older than healthy controls of the same chronological age. Even DMT-naïve adults were 4.90 years older, and pediatric patients showed a 6.98-year acceleration.
  • Longitudinal Pace: In follow-up studies, PwMS aged at a rate of 1.19 metabolomic years for every 1 chronological year, significantly faster than healthy controls.
  • Social Impact: For every 10-percentile increase in social disadvantage (ADI), PwMS experienced an additional 0.63-year increase in age acceleration.

Limitations and Future Work

The authors acknowledge several limitations:

  • Metabolite Overlap: Because the study was retrospective, they couldn't use the exact full set of metabolites from the original aging clock, leading to some variation in how mAge was calculated across cohorts.
  • Pediatric Scaling: The aging clock used was trained on adults. While it effectively showed relative differences between sick and healthy children, the absolute age values for the pediatric group are likely inflated.
  • Diversity: The JHU cohort was predominantly White. Future work needs to include more racially and ethnically diverse populations to see if these aging patterns hold true across different backgrounds.
  • Causality: While the link between social deprivation and aging is clear, the study cannot definitively prove that the environment causes the aging; prospective studies are needed to unravel the specific mediators (e.g., diet, chronic stress, pollution).

Summary updated

Abstract

We demonstrated accelerated mAge in adult and pediatric-onset PwMS and its association with social disadvantage.
BibTeX
@misc{siavoshi2025accelerated,
  author = {Fatemeh Siavoshi and Rezvan Noroozi and Gina Chang and Vinícius Andreoli Schoeps and Matthew D. Smith and Farren Briggs and Jennifer Graves and Emmanuelle Waubant and Ellen M. Mowry and Peter A. Calabresi and Pavan Bhargava and Kathryn C. Fitzgerald},
  title = {{Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis}},
  year = {2025},
  doi = {10.1101/2025.01.29.25321260},
  howpublished = {medRxiv},
}
Figure